HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biehl, K. J. Articles by Bradley, J. Search for Related Content PubMed Articles by Biehl, K. J. Articles by Bradley, J.

Reply: ¹⁸F-FDG PET in Planning Radiation Treatment of Non–Small Cell Lung Cancer: Where Exactly Is the Tumor?

Washington University School of Medicine, St. Louis, Missouri

REPLY: Thank you for the opportunity to comment on the letter to the editor from Drs. Dahele and Ung. The group from Toronto–Sunnybrook Regional Cancer Center has a longstanding interest and expertise on the subject of PET-planned radiation therapy. We thank them for their continued contributions to the field.

Our objective in publishing our article (1) was to point out that the current methods used to contour ¹⁸F-FDG PET for purposes of defining tumor volumes for radiation therapy are problematic. The use of a single threshold for all lung cancers is not appropriate because of the many factors that influence it, including tumor volume and heterogeneity. Currently, PET does not have the spatial resolution or tumor-tracking abilities of 4-dimensional CT. The ongoing RTOG-0515 trial (2) uses CT to contour lung cancer volumes, applying ¹⁸F-FDG PET as a guide. The spatial and motion issues are not managed well by PET presently. With the development of gated PET, improvements in the technology are coming.

Drs. Dahele and Ung point out that PET contouring has some advantages, such as improved interobserver consistency and forgiveness when the operator cannot distinguish between normal and abnormal anatomy. These advantages are likely to persist as technology advances. An obvious extension would be the development of automated tumor-contouring tools for treatment planning. Collection of PET-based tumor contours and histopathology specimens, as is being performed in the PET START Trial (3), would be an excellent database on which to develop and test such tools.

We agree that the correlation of PET with tumor pathology is of vital importance. We look forward to the completion of the trial and the reporting of the results.

FOOTNOTES

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

References

1. Biehl KJ, Kong F-M, Dehdashti F, et al. ¹⁸F-FDG PET definition of gross tumor volume for radiotherapy of non–small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med. 2006;47:1808–1812.[Abstract/Free Full Text]
2. ClinicalTrials.gov Web site. Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients with Stage II or Stage III Non-Small Cell Lung Cancer. Available at: http://clinicaltrials.gov/ct/show/NCT00310219?order=1. Accessed June 5, 2007.
3. National Cancer Institute Web site. Positron Emission Tomography (PET) Imaging in Stage III Non-Small Cell Lung Cancer (PET START Trial). Available at: http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=447273&version=patient&protocolsearchid=3067525#Objectives_CDR0000447273. Accessed May 22, 2007.

This article has been cited by other articles:

				M. T. Burniston and D. J. Wilson Radioiodine Ablation Outcomes After Imaging with 123I or 131I: Is No News Good News? J. Nucl. Med., January 1, 2008; 49(1): 166 - 166. [Full Text] [PDF]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biehl, K. J. Articles by Bradley, J. Search for Related Content PubMed Articles by Biehl, K. J. Articles by Bradley, J.